Anti-GAD65 autoantibody levels measured by ELISA and alternative types of immunoassays in relation to neuropsychiatric diseases versus diabetes mellitus type 1

MLA

Shenghua Zong, et al. “Anti-GAD65 Autoantibody Levels Measured by ELISA and Alternative Types of Immunoassays in Relation to Neuropsychiatric Diseases versus Diabetes Mellitus Type 1.” Frontiers in Neurology, vol. 14, May 2023. EBSCOhost, https://doi.org/10.3389/fneur.2023.1111063.

APA

Shenghua Zong, Anita M. Vinke, Peng Du, Carolin Hoffmann, Marina Mané-Damas, Peter C. Molenaar, Jan G. M. C. Damoiseaux, Mario Losen, Rob P. W. Rouhl, & Pilar Martinez-Martinez. (2023). Anti-GAD65 autoantibody levels measured by ELISA and alternative types of immunoassays in relation to neuropsychiatric diseases versus diabetes mellitus type 1. Frontiers in Neurology, 14. https://doi.org/10.3389/fneur.2023.1111063

Chicago

Shenghua Zong, Anita M. Vinke, Peng Du, Carolin Hoffmann, Marina Mané-Damas, Peter C. Molenaar, Jan G. M. C. Damoiseaux, Mario Losen, Rob P. W. Rouhl, and Pilar Martinez-Martinez. 2023. “Anti-GAD65 Autoantibody Levels Measured by ELISA and Alternative Types of Immunoassays in Relation to Neuropsychiatric Diseases versus Diabetes Mellitus Type 1.” Frontiers in Neurology 14 (May). doi:10.3389/fneur.2023.1111063.